TY  - BOOK
AU  - Kodama, Samantha
TI  - Pharmacologic Treatments for PCOS Patients. [Review]
SN  - 0009-9201
PY  - 2021///
KW  - *Infertility, Female
KW  - *Polycystic Ovary Syndrome
KW  - Adult
KW  - Female
KW  - Humans
KW  - Infertility, Female/dt [Drug Therapy]
KW  - Infertility, Female/et [Etiology]
KW  - Life Style
KW  - Menstruation Disturbances
KW  - Polycystic Ovary Syndrome/dt [Drug Therapy]
KW  - MedStar Washington Hospital Center
KW  - Obstetrics and Gynecology
KW  - Journal Article
N1  - Available online from MWHC library: March 1996 - present, Available in print through MWHC library: 1999 - March 2003
N2  - Polycystic ovarian syndrome is the most common endocrinopathy in reproductive-aged women and has a vast array of clinical manifestations. Common clinical presentations of the disorder include anovulatory infertility, menstrual disorders, cutaneous symptoms secondary to androgen excess, metabolic abnormalities and mental health issues. If the condition is left unaddressed or inadequately treated, long-term sequelae such as endometrial hyperplasia, diabetes mellitus and dyslipidemia may ensue, therefore it is imperative for clinicians to address each component of the syndrome. When initial lifestyle changes and dietary modifications do not suffice or fail, pharmacologic therapy should be considered, and when deemed appropriate treatment should be initiated. This review describes the pharmacologic options available to combat the various sequelae commonly seen in women with polycystic ovarian syndrome. Copyright (c) 2020 Wolters Kluwer Health, Inc. All rights reserved
UR  - https://dx.doi.org/10.1097/GRF.0000000000000597
ER  -